 |
 |
 |
|
|
|
|
|
|
|
|
|
Controlled/Sustained Release Taste-Masking Astruc, J., and A. Sambot, 1970. Ion-exchange resin: spiramycin compositions. Patent GB 1,180,233. Borodkin, S., and D.P. Sundberg, 1971. Chewable tablets including coated particles of psuedo-ephedine-weak cation exchange resin. Patent US 3,594,470.
Other Miles Laboratories, Inc., 1970, Detection device
for enzymes and other factors in body fluids. |
|
|
|
|
|
|
|
|
 |
| Tablet Disintegrant Aboutaleb, A.E., A.M. Attia, and F.S. Habib, 1983. Effect of various disintegrants on the availability of directly compressed sulfadimidine tablets. Pharmazie, 38 (7): 473-475. Arnold, J.D., 1986. Dihydrocodine/ibuprofen phamaceutical compositions. Patent US 4,571,400. Borodkin, S., and M.H. Yunker, 1970. Interaction of amine drugs with a polycarboxylic acid ion exchange resin. J.Pharm. Sci. 59 (4): 481-486. Dawson, W., 1983. Treating hypersensitivity disease with benzoxazole derivatives. Patent US 4,416,892. Graf, E., A.H. Ghanem, and H.M. Mahmoud, 1984. Studies on the direct compression of pharmaceuticals. 15: Effect of compression force on sulfadiazine-encompress tablets. Pharm. Ind. 46 (3): 279-284. Graf, E., A.H. Ghanem, and H.M. Mahmoud, 1985. Studies on the direct compression of pharmaceuticals. 18: Effect of aging on some physical properties of tablet formulations containing certain types of disintegrants. Pharm. Ind. 47 (7) 773-776. Jonas,E. et al. Water Uptake Kinetics and Swelling Force of Some Disintegrants. Pharmazie (1996), 51(8), 605. Khan, K.A., and C.T. Rhodes, 1975. Water-sorption properties of tablet disintegrants. J. Pharm. Sci 64(3): 447-451. Khan, K.A., and C.T. Rhodes, 1971. Effect of compaction pressure on dissolution times of some direct compression systems. J. Pharm, Pharmacol., 23 (Suppl.). Mantovani, V., L. Stanzani, and A.P. Venturini, 1978. Erythomycin-based antibiotic preparation. Patent DE 2,745,946. Peppas, N.A., and P. Colombo, 1989. Development of disintegration forces during water penetration in porous pharmaceutical systems. J. Contr. Release 10: 245-250. Sakr, A.M., A.E. Aboutaleb, H.M. Elsabagh, and A.M. Aly, 1979. Comparative effectiveness of certain disintegrants on directly compressed sulfadimidine tablets. Egypt. J. Pharm. Sci. 18 (3): 219-233. Tan, H.S., and B.M. Wegman, 1986. Tablets comprising trimethoprim and a sulfonamide. Patent EP 199,855. Waetjen, F., M. Engelstoff, J.B. Hansen, and L.H. Jensen, 1986. Oxadiazolylimidazobenzodiazepines, their use as anticonvulsants and anxiolytics. Patent US 4,622,320. Taste Masking |
| Amberlite
IRP69 Application Reference List |
| Cholestyamine
Application Reference List |
|
|
|
|
|
|
| Irwin, W. J, R. MacHale,
and P. J. Watts (1990). Drug-delivery by ion exchange. Part VII: Release
of acidic drugs from anionic exchange resinate complexes. Drug. Dev. Ind.
Pharm. 16(6):883-898. Sriwongjanya, Mongkol; Bodmeier, Roland; Effect of ion exchange resins on the drug release from matrix tablets; College Pharmacy, Freie Universitaet Berlin, Berlin, D-12169, Germany; Eur. J. Pharm. Biopharm. (1998), 46(3), 321-327. Polli, Gerald P. and Shoop, Clyde E., (Merck and Co. USA), 1976. Palatable cholestyramine coacervate compositions. Patent US 3,974,272. Brauns H. A., Polli, Gerald P and Shoop, Clyde E., (Merck and Co., USA), 1974. Cholestyramine containing coacervate. Ger. Offen DE 2,344,090. Kunin, Robert; Blood cholesterol reducing pharmaceutical composition; 1998; Patent US 5840339. |
 |
 |
 |
 |
Amberlite™ IRP and Duolite™ AP143
Applications Reference List
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |